366 results
Page 5 of 19
8-K
EX-1.1
h4yx1rjz
23 Jan 20
Entry into a Material Definitive Agreement
4:07pm
424B5
z7okpagy
23 Jan 20
Prospectus supplement for primary offering
4:05pm
424B5
odjdchbyhl
22 Jan 20
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
nxj60wn1
13 Jan 20
Results of Operations and Financial Condition
6:07am
8-K
yjoyngt4ls7 4mu
13 Jan 20
Results of Operations and Financial Condition
6:07am
S-8
EX-23.1
mbgxcwqddcn
20 Dec 19
Registration of securities for employees
1:34pm
S-8
EX-23.1
ouk423d3vq g6
20 Dec 19
Registration of securities for employees
1:32pm
S-8 POS
EX-23.1
sut2634
20 Dec 19
Registration of securities for employees (post-effective amendment)
1:28pm
S-8 POS
EX-23.1
xwjfoliu6in2lyb
20 Dec 19
Registration of securities for employees (post-effective amendment)
1:22pm
8-K
EX-10.1
0n4 8cyuvqm
20 Dec 19
Departure of Directors or Certain Officers
7:03am
8-K
EX-99.1
v7pv5q9ea
30 Sep 19
ImmunoGen Presents Full Data from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine in Ovarian Cancer at ESMO
8:08am
8-K
r1na5wv9cy9 oc
24 Jun 19
Submission of Matters to a Vote of Security Holders
11:54am
8-K
2tijzfcdmq23rvuy4do4
15 May 19
Other Events
6:39am
DEFA14A
hky5kyi
30 Apr 19
Additional proxy soliciting materials
12:23pm
8-K
gvgyodlw 2u636n
1 Mar 19
Entry into a Material Definitive Agreement
7:02am